• Performance of CETP inhibitors vexing

    5 days ago - By Healio

    PHILADELPHIA - While cholesterol ester transfer protein inhibitors raise HDL and some lower LDL, they have so far not shown any impact on CV outcomes and their future is unclear, an expert said at the National Lipid Association Scientific Sessions.Peter H. Jones, MD, FNLA, associate professor at Methodist DeBakey Heart and Vascular Center, Baylor College of Medicine, Houston, said that while there is strong epidemiologic evidence for an inverse relationship between HDL levels and CV risk, studies of CETP inhibitors and other mechanisms of raising HDL have not demonstrated an effect on CV...
    Read more ...